After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
BPMC belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Blueprint Medicines Corp is $5.71B. A total of 1.39 million shares were traded on the day, compared to an average of 883.89K shares.
Insider Activity
Investors also take into account insider trades in predicting how the stock will perform in the future. During the recent three months, BPMC has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 0 BUYs and 0 SELLs from insiders. Insiders purchased 0 shares during that period but sold 0.
In the most recent transaction, Hurley Ariel sold 3,203 shares of BPMC for 92.62 per share on Mar 03 ’25. After the transaction, the PRINCIPAL ACCOUNTING OFFICER now owns 18,270 company shares. In a previous transaction on Mar 03 ’25, ARIEL HURLEY bought 2,250 shares at 96.57 per share.
Among the insiders who sold shares, Rossi Christina disposed of 2,274 shares on Feb 20 ’25 at a per-share price of $95.14. This resulted in the CHIEF OPERATING OFFICER holding 64,835 shares of BPMC after the transaction. In another insider transaction, Haviland Kate sold 1,446 shares at $110.24 per share on Jan 21 ’25. Company shares held by the CHIEF EXECUTIVE OFFICER now total 149,378.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for BPMC in the last 3 months, the mean price target is $126.79 with high estimates of $169.00 and low estimates of $83.00. In terms of 52-week highs and lows, BPMC has a high of $121.90 and a low of $80.68.
As of this writing, BPMC has an earnings estimate of -$0.34 per share for the current quarter. EPS was calculated based on a consensus of 6.0 estimates, with a high estimate of $0.48 per share and a lower estimate of -$0.9.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. BPMC’s latest balance sheet shows that the firm has $477.11M in Cash & Short Term Investments as of fiscal 2021. There were $111.41M in debt and $149.76M in liabilities at the time. Its Book Value Per Share was $4.69, while its Total Shareholder’s Equity was $970.74M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BPMC is Buy with a score of 4.25.
